Al-Wabel, N. A., Strauch, S. M., Keene, B. W., Nakayama, T., & Hamlin, R. L. (2002). Electrocardiographic and hemodynamic effects of cisapride alone and combined with erythromycin in anesthetized dogs. Cardiovascular toxicology, 2(3), 195-207.
Alvarado, A. (2017). Dual bronchodilator therapy: A review. Clin Res Trials, 3, 1-12.
Andreas, S., Bothner, U., Trampisch, M., Haensel, M., Buhl, R., & Alter, P. (2018). Effect of long-acting β2-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients. Pulmonary pharmacology & therapeutics, 52, 1-6.
Arias-Reyes, J., Matos-Martínez, M., Velásquez-Jones, L., & Dubey-Ortega, L. (1989). Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency. Boletin Medico del Hospital Infantil de Mexico, 46(9), 603-606.
Bremner, P., Woodman, K., Burgess, C., Crane, J., Purdie, G., Pearce, N., & Beasley, R. (1993). A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. European Respiratory Journal, 6(2), 204-210.
Buonavoglia, C., & Martella, V. (2007). Canine respiratory viruses. Veterinary research, 38(2), 355-373.
Collomp, K., Candau, R., Lasne, F., Labsy, Z., Prefaut, C., & De Ceaurriz, J. (2000). Effects of short-term oral salbutamol administration on exercise endurance and metabolism. Journal of Applied Physiology, 89(2), 430-436.
Collomp, K., Candau, R., Millet, G., Mucci, P., Borrani, F., Prefaut, C., & De Ceaurriz, J. (2002). Effects of salbutamol and caffeine ingestion on exercise metabolism and performance. International journal of sports medicine, 23(08), 549-554.
Descalzi, D., Folli, C., Nicolini, G., Riccio, A., Gamalero, C., Scordamaglia, F., & Canonica, G. (2008). Anti‐proliferative and anti‐remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. Allergy, 63(4), 432-437.
Faulds, D., Hollingshead, L. M., & Goa, K. L. (1991). Formoterol. Drugs, 42(1), 115-137.
Goldkorn, A., Diotto, P., Burgess, C., Weatherall, M., Holt, S., Beasley, R., & Siebers, R. (2004). The pulmonary and extra‐pulmonary effects of high‐dose formoterol in COPD: A comparison with salbutamol. Respirology, 9(1), 102-108.
Guhan, A., Cooper, S., Oborne, J., Lewis, S., Bennett, J., & Tattersfield, A. (2000). Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax, 55(8), 650-656.
Jasiński, T., Owczuk, R., & Wujtewicz, M. (2018). The effect of nebulized salbutamol on atrial electrical properties in mechanically ventilated critically ill patients—a randomized, double-blind study. Anaesthesiology intensive therapy, 50(4).
Kaffash Elahi, R., mohajeri, d., nourazar, a., & Bagheri, Y. (2019). Study on Carbamazepine induced electrocardiographic, blood pressure and echocardiographic changes in the dog. Scientific Journal Management System, 13(2 (50) Summer), 177-186.
Maki, K. C., Skorodin, M. S., Jessen, J. H., & Laghi, F. (1996). Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men. Metabolism, 45(6), 712-717.
Novodvorsky, P., Bernjak, A., Robinson, E. J., Iqbal, A., Macdonald, I. A., Jacques, R. M., Marques, J. L., Sheridan, P. J., & Heller, S. R. (2018). Salbutamol‐induced electrophysiological changes show no correlation with electrophysiological changes during hyperinsulinaemic–hypoglycaemic clamp in young people with Type 1 diabetes. Diabetic Medicine, 35(9), 1264-1272.
Nunes, C., Pereira, A. M., & Morais-Almeida, M. (2017). Asthma costs and social impact. Asthma research and practice, 3(1), 1.
Padrid, P. (2000). Canine and feline pleural disease. Veterinary Clinics: Small Animal Practice, 30(6), 1295-1308.
Parichatikanond, W., Nishimura, A., Nishida, M., & Mangmool, S. (2018). Prolonged stimulation of β2-adrenergic receptor with β2-agonists impairs insulin actions in H9c2 cells. Journal of pharmacological sciences, 138 (3), 184-191.
Robertson, C., Norden, M., Fitzgerald, D., Connor, F., Van Asperen, P., Cooper, P., Francis, P., & Allen, H. (1998). Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler. Journal of paediatrics and child health, 34(2), 142-146.
Rosenborg, J., Bengtsson, T., Larsson, P., Blomgren, A., Persson, G., & Lötvall, J. (2000). Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. European journal of clinical pharmacology, 56(5), 363-370.
Sahan, M., Yılmaz, M., Gokel, Y., Erden, E., & Karakus, A. (2013). Nebulized salbutamol for asthma: Effects on serum potassium and phosphate levels at the 60 min. Revista Portuguesa de Pneumologia (English Edition), 19(5), 200-203.
Smith, A., Banks, J., Buchanan, K., Cheong, B., & Gunawardena, K. (1992). Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. QJM: An International Journal of Medicine, 82(1), 71-80.
Vale, A. (2016). β2-Agonists. Medicine, 44(3), 146.
Varegg, M. S., Kløverød, K. M., Austnes, M. K., Siwinska, N., Slowikowska, M., Zak, A., & Niedzwiedz, A. (2019). The effect of single pretreatment with salbutamol on recovery of bronchoalveolar lavage fluid in horses with suspected or confirmed severe equine asthma. Journal of veterinary internal medicine, 33(2), 976-980.
Velasquez, L., & Muñoz, R. (1991). The treatment of hyperkalemia with salbutamol. Boletin Medico del Hospital Infantil de Mexico, 48(11), 77.779-5.
)